Copyright
©The Author(s) 2025.
World J Methodol. Mar 20, 2025; 15(1): 97814
Published online Mar 20, 2025. doi: 10.5662/wjm.v15.i1.97814
Published online Mar 20, 2025. doi: 10.5662/wjm.v15.i1.97814
Table 1 Applications of minimal clinically important difference in various medical specialties
| Specialty | Application of MCID | Key outcome measures | Example of impact |
| Orthopedics | Evaluation of surgical outcomes (knee/hip replacements) | Pain reduction; mobility enhancement | Determines the significance of improvements in joint function |
| Oncology | Assessing treatment impact on quality of life | Symptoms management; Side effect severity | Helps in managing therapy options considering patient perceptions of change |
| Neurology | Effectiveness in treatment of chronic neurological diseases | Disease progression; Motor function | Utilized in assessing therapies in conditions like multiple sclerosis |
| Psychiatry | Efficacy of treatments for mood disorders | Changes in psychiatric rating scales | Crucial for interpreting clinically meaningful changes in mental health |
| Pulmonology/Cardiology | Patient-reported outcomes for respiratory and heart diseases | Breathlessness; Exercise capacity | Assists in evaluating interventions impacting daily activities |
| Physical therapy and rehabilitation | Setting goals and measuring progress in recovery | Pain reduction; Functional recovery | Guides clinicians in tailoring rehabilitation programs |
Table 2 Challenges and controversies in minimal clinically important difference implementation
| Challenge category | Specific issue | Impact on MCID application | Proposed solution |
| Methodological | Variability in calculation methods | Leads to inconsistent MCID values | Standardize calculation methods and develop guidelines |
| Interpretational | Misinterpretation of what changes are clinically important | Can result in inappropriate treatment decisions | Educate clinicians on nuanced interpretation of MCID values |
| Demographic influence | Variations in MCID across different patient demographics | Difficulty applying MCID universally | Conduct cross-cultural studies to validate MCID in diverse populations |
| Clinical application | Generic use in individual patient management | May overlook individual patient needs | Tailor MCID application by incorporating individual patient preferences |
| Research and policy | Lack of standardized reporting in research | Hampers the comparability of studies | Implement uniform reporting standards for MCID findings |
| Patient involvement | Limited patient input in setting MCID thresholds | May not reflect true patient priorities | Increase patient involvement through advisory panels and participatory research |
- Citation: Jeyaraman N, Jeyaraman M, Ramasubramanian S, Balaji S, Muthu S. Beyond statistical significance: Embracing minimal clinically important difference for better patient care. World J Methodol 2025; 15(1): 97814
- URL: https://www.wjgnet.com/2222-0682/full/v15/i1/97814.htm
- DOI: https://dx.doi.org/10.5662/wjm.v15.i1.97814
